{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:42:50Z","timestamp":1773877370341,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"am","delay-in-days":657,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K07354"],"award-info":[{"award-number":["19K07354"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.bbrc.2022.02.035","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T10:52:32Z","timestamp":1644490352000},"page":"69-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["TTR exon-humanized mouse optimal for verifying new therapies for FAP"],"prefix":"10.1016","volume":"599","author":[{"given":"Zhenghua","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Kanazashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimi","family":"Tokashiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Fujikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7384-3776","authenticated-orcid":false,"given":"Ayaka","family":"Okagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoko","family":"Haruna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomo-o","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2022.02.035_bib1","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/brain\/75.3.408","article-title":"A\u00a0peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves","volume":"75","author":"Andrade","year":"1952","journal-title":"Brain"},{"key":"10.1016\/j.bbrc.2022.02.035_bib2","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1073\/pnas.81.3.694","article-title":"Primary structure of an amyloid prealbumin and its plasma precursor in a heredofamilial polyneuropathy of Swedish origin","volume":"81","author":"Dwulet","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2022.02.035_bib3","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0006-291X(83)80224-1","article-title":"Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type)","volume":"116","author":"Tawara","year":"1983","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2022.02.035_bib4","first-page":"391","article-title":"Senile systemic amyloidosis","volume":"117","author":"Pitkanen","year":"1984","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2022.02.035_bib5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0002-9440(10)63123-9","article-title":"Cysteine 10 is a key residue in amyloidogenesis of human transthyretin Val30Met","volume":"164","author":"Takaoka","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2022.02.035_bib6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1023\/A:1018454527309","article-title":"Comparison of amyloid deposition in two lines of transgenic mouse that model familial amyloidotic polyneuropathy, type I","volume":"6","author":"Takaoka","year":"1997","journal-title":"Transgenic Res."},{"key":"10.1016\/j.bbrc.2022.02.035_bib7","first-page":"403","article-title":"Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met30) gene. Pathologic similarity to human familial amyloidotic polyneuropathy, type I","volume":"138","author":"Yi","year":"1991","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2022.02.035_bib8","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/j.1365-2443.2008.01242.x","article-title":"Inconsistency between hepatic expression and serum concentration of transthyretin in mice humanized at the transthyretin locus","volume":"13","author":"Zhao","year":"2008","journal-title":"Gene Cell."},{"key":"10.1016\/j.bbrc.2022.02.035_bib9","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s11248-008-9180-9","article-title":"Specific pathogen free conditions prevent transthyretin amyloidosis in mouse models","volume":"17","author":"Inoue","year":"2008","journal-title":"Transgenic Res."},{"key":"10.1016\/j.bbrc.2022.02.035_bib10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41374-017-0019-y","article-title":"Amyloid deposition in a mouse model humanized at the transthyretin and retinol-binding protein 4 loci","volume":"98","author":"Li","year":"2018","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbrc.2022.02.035_bib11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/oxfordjournals.jbchem.a124705","article-title":"A\u00a06-kb upstream region of the human transthyretin gene can direct developmental, tissue-specific, and quantitatively normal expression in transgenic mouse","volume":"117","author":"Nagata","year":"1995","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.bbrc.2022.02.035_bib12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1538\/expanim.51.309","article-title":"Effect of the intestinal flora on amyloid deposition in a transgenic mouse model of familial amyloidotic polyneuropathy","volume":"51","author":"Noguchi","year":"2002","journal-title":"Exp. Anim."},{"key":"10.1016\/j.bbrc.2022.02.035_bib13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/dvg.1020080404","article-title":"Tissue-specific and developmental expression of human transthyretin gene in transgenic mice","volume":"8","author":"Yamamura","year":"1987","journal-title":"Dev. Genet."},{"key":"10.1016\/j.bbrc.2022.02.035_bib14","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1074\/jbc.M708028200","article-title":"Human-murine transthyretin heterotetramers are kinetically stable and non-amyloidogenic. A lesson in the generation of transgenic models of diseases involving oligomeric proteins","volume":"283","author":"Reixach","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2022.02.035_bib15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/13506120701464396","article-title":"In\u00a0vivo stabilization of mutant human transthyretin in transgenic mice","volume":"14","author":"Tagoe","year":"2007","journal-title":"Amyloid"},{"key":"10.1016\/j.bbrc.2022.02.035_bib16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/labinvest.2016.156","article-title":"Rescue of retinal morphology and function in a humanized mouse at the mouse retinol-binding protein locus","volume":"97","author":"Liu","year":"2017","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbrc.2022.02.035_bib17","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1038\/srep03355","article-title":"Generation of mutant mice by pronuclear injection of circular plasmid expressing Cas9 and single guided RNA","volume":"3","author":"Mashiko","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2022.02.035_bib18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neures.2007.01.004","article-title":"Conditional gene targeting on the pure C57BL\/6 genetic background","volume":"58","author":"Mishina","year":"2007","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.bbrc.2022.02.035_bib19","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1128\/MCB.00181-15","article-title":"Transgenic mice overexpressing serum retinol-binding protein develop progressive retinal degeneration through a retinoid-independent mechanism","volume":"35","author":"Du","year":"2015","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2022.02.035_bib20","doi-asserted-by":"crossref","first-page":"30191","DOI":"10.1074\/jbc.M205046200","article-title":"Muscle expression of human retinol-binding protein (RBP). Suppression of the visual defect of RBP knockout mice","volume":"277","author":"Quadro","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2022.02.035_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0083-6729(04)69010-8","article-title":"Plasma retinol-binding protein: structure and interactions with retinol, retinoids, and transthyretin","volume":"69","author":"Zanotti","year":"2004","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.bbrc.2022.02.035_bib22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2144\/000114339","article-title":"Highly efficient CRISPR\/HDR-mediated knock-in for mouse embryonic stem cells and zygotes","volume":"59","author":"Wang","year":"2015","journal-title":"Biotechniques"},{"key":"10.1016\/j.bbrc.2022.02.035_bib23","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1002\/bit.27441","article-title":"Crispr\/Cas9-mediated cleavages facilitate homologous recombination during genetic engineering of a large chromosomal region","volume":"117","author":"Zhang","year":"2020","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.bbrc.2022.02.035_bib24","first-page":"1497","article-title":"Analysis of amyloid deposition in a transgenic mouse model of homozygous familial amyloidotic polyneuropathy","volume":"150","author":"Kohno","year":"1997","journal-title":"Am. J. Pathol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X22002248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X22002248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:15:09Z","timestamp":1757765709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X22002248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":24,"alternative-id":["S0006291X22002248"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.02.035","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TTR exon-humanized mouse optimal for verifying new therapies for FAP","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.02.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}